Irinotecan and anorexia 
Irinotecan and anorexia Patient Reports February 12, 2012
Irinotecan Side Effects Report #4656690-1
Irinotecan side effect was reported by a Consumer or non-health professional from on Apr 27, 2005. Male patient, 73 years of age, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, blood pressure decreased, condition aggravated, disseminated intravascular coagulation, escherichia infection, malaise, metastasis, neoplasm progression, pancytopenia. Irinotecan dosage: 100 MG, INTRAVENOUS. During the same period patient was treated with ZANTAC, FLUOROURACIL, CALCIUM LEVOFOLINATE. Patient was hospitalized and became disabled. Patient died on 02/26/2005.
Irinotecan Side Effects Report #4704326-3
Irinotecan side effect was reported by a Consumer or non-health professional from on Apr 27, 2005. Male patient, 73 years of age, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, anorexia, blood pressure decreased, condition aggravated, disseminated intravascular coagulation, escherichia infection, malaise, pancytopenia, sepsis
. Irinotecan dosage: 100 MG INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM FOLINATE. Patient was hospitalized and became disabled. Patient died on 02/26/2005.Irinotecan Side Effects Report #4652214-3
Irinotecan side effect was reported by a Physician from on Apr 19, 2005. Male patient, 56 years of age, weighting 108.0 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abdominal pain
, anorexia, duodenal perforation, duodenal ulcer, malaise, nausea , neuroblastoma , stress . Irinotecan dosage: 60 MG INTRAVENOUS. During the same period patient was treated with METHYLPREDNISOLOONE SUCCINATE, CALCIUM LEVOFOLINATE, FENTANYL, MORPHINE, FLUOROURACIL, BETAMETHASONE, FAMOTIDINE. Patient recovered.Irinotecan Side Effects Report #4950290-1
Irinotecan side effect was reported by a Physician from JAPAN on Mar 02, 2006. Female patient, 52 years of age, weighting 97.00 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, discomfort, electrocardiogram t wave inversion, fall
, loss of consciousness, malaise, nausea , urinary incontinence . Irinotecan dosage: 130 MG/BODY (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4996188-4
Irinotecan side effect was reported by a Physician from JAPAN on Apr 21, 2006. Female patient, 52 years of age, weighting 97.00 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, dehydration, discomfort, electrocardiogram abnormal, fall
, infusion related reaction, malaise, specific gravity urine increased, syncope. Irinotecan dosage: 130 MG/BODY INTERMITTENT, INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CALCIUM LEVOFOLINATE. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4776561-X
Irinotecan side effect was reported by a Physician from JAPAN on Sept 02, 2005. Male patient, 42 years of age, weighting 105.8 lb, was diagnosed with rectal cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, bone marrow depression, coagulopathy, condition aggravated, dehydration, diarrhoea, disseminated intravascular coagulation, haemorrhagic diathesis, malaise. Irinotecan dosage: 80 MG (1 D), INTRAVENOUS; 60 MG (1 D), INTRAVENOUS. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE, FLUOROURACIL, STRONG, CALCIUM LEVOFOLINATE, CALCIUM LEVOFOLINATE. Patient was hospitalized. Patient died on 08/29/2005.
Irinotecan Side Effects Report #5322815-8
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on Apr 25, 2007. Male patient was diagnosed with rectal cancer, hypertension, diabetes mellitus and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, diarrhoea, disseminated intravascular coagulation, dyspepsia, nausea
, pyrexia, renal impairment, sepsis . Irinotecan dosage: DAILY DOSE:230MG. During the same period patient was treated with CALCIUM FOLINATE, FLUOROURACIL, NORVASC, ALMARL, AMARYL, OLMETEC, GLUCOBAY. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5333991-5
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on May 14, 2007. Male patient was diagnosed with rectal cancer, hypertension, diabetes mellitus and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, diarrhoea, disseminated intravascular coagulation, dyspepsia, nausea
, pyrexia, renal impairment, sepsis . Irinotecan dosage: DAILY DOSE:230MG. During the same period patient was treated with CALCIUM FOLINATE, FLUOROURACIL, NORVASC, ALMARL, AMARYL, OLMETEC, GLUCOBAY. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5348424-2
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on May 25, 2007. Male patient was diagnosed with rectal cancer, hypertension, diabetes mellitus and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, blood bilirubin increased, diarrhoea, disseminated intravascular coagulation, nausea
, pyrexia, renal impairment, sepsis . Irinotecan dosage: DAILY DOSE:150MG/M2. During the same period patient was treated with CALCIUM FOLINATE, FLUOROURACIL, NORVASC, ALMARL, AMARYL, OLMETEC, GLUCOBAY. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5072971-4
Irinotecan side effect was reported by a Physician from JAPAN on July 20, 2006. Female patient, 82 years of age, weighting 72.75 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, interstitial lung disease, leukopenia, lung infection, lymphangiosis carcinomatosa, malaise, malignant ascites, malignant neoplasm progression, pyrexia. Irinotecan dosage: 25 MG (1 IN 1 WK), INTRAVENOUS. During the same period patient was treated with LANSOPRAZOLE, JUZENTAIHOTO, ALLOID, FLUCALIN. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #4693777-1
Irinotecan side effect was reported by a Physician from on June 03, 2005. Female patient, 68 years of age, weighting 81.57 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, bone marrow depression, condition aggravated, cyanosis, disease progression, disease recurrence, infection
, interstitial lung disease, malaise. Irinotecan dosage: unknown. During the same period patient was treated with GRAN, ETOPOSIDE, TAXOTERE. Patient was hospitalized. Patient died on 03/03/2005.Irinotecan Side Effects Report #5117954-0
Irinotecan side effect was reported by a Physician from JAPAN on Sept 13, 2006. Female patient, 67 years of age, weighting 81.57 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, bone marrow failure, condition aggravated, infection
, interstitial lung disease, malaise, malnutrition, metastases to spleen. Irinotecan dosage: unknown. During the same period patient was treated with NEUPOGEN, ETOPOSIDE, TAXOTERE. Patient was hospitalized. Patient died on 03/03/2005.Irinotecan Side Effects Report #4652226-X
Irinotecan side effect was reported by a Physician from on Apr 19, 2005. Female patient, 67 years of age, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anaemia, anorexia, blood pressure decreased, diarrhoea, disseminated intravascular coagulation, jaundice
, vomiting. Irinotecan dosage: 50 MG INTRAVENOUS. During the same period patient was treated with CISPLATIN. Patient died on 04/04/2005.Irinotecan Side Effects Report #4664707-3
Irinotecan side effect was reported by a Physician from on May 02, 2005. Female patient, 67 years of age, weighting 81.57 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abnormal faeces, anaemia, anorexia, blood pressure decreased, bone marrow depression, depressed level of consciousness, diarrhoea, disseminated intravascular coagulation, jaundice
. Irinotecan dosage: 50 MG, INTRAVENOUS. During the same period patient was treated with CISPLATIN, DICLOFENAC, GLYCERYL TRINITRATE, HERBAL PREPARATION, MAGNESIUM OXIDE, LOPERAMIDE HYDROCHLORIDE, METOCLOPRAMIDE. Patient died on 04/04/2005.Irinotecan Side Effects Report #4696146-3
Irinotecan side effect was reported by a Physician from on June 07, 2005. Female patient, 67 years of age, weighting 81.57 lb, was diagnosed with ovarian cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abnormal faeces, anorexia, blood pressure decreased, bone marrow depression, depressed level of consciousness, diarrhoea, disseminated intravascular coagulation, hyperbilirubinaemia, jaundice
. Irinotecan dosage: 50 MG, INTRAVENOUS. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE SOLUTION, CISPLATIN, VOLTAREN, VASOLATOR, HANGE, MAGNESIUM HYDROXIDE, LOPEMIN, PRIMPERAN. Patient was hospitalized. Patient died on 04/04/2005.Irinotecan Side Effects Report #5094325-7
Irinotecan side effect was reported by a Health Professional from UNITED STATES on Aug 30, 2006. Female patient, weighting 114.6 lb, was diagnosed with oesophageal carcinoma and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, asthenia, dehydration, fatigue, incontinence, leukopenia, malnutrition, nausea
, neutrophil count abnormal. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN, CETUXIMAB, MIRALAX, FOSAMAX, ATIVAN, CLINDAGEL, CLONAZEPAM. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4661100-4
Irinotecan side effect was reported by a Health Professional from on Apr 28, 2005. Female patient, 70 years of age, weighting 137.6 lb, was diagnosed with non-small cell lung cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, blood lactate dehydrogenase increased, crepitations, diarrhoea, interstitial lung disease, nausea
. Irinotecan dosage: 152 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with GEMCITABINE HYDROCHLORIDE, LOSARTAN POTASSIUM, TRICHLORMETHIAZIDE, GLICLAZIDE, ACARBOSE, ATORVASTATIN CALCIUM, BUTENAFINE, ROHTO. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5683261-0
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on Mar 12, 2008. Male patient, weighting 116.8 lb, was diagnosed with non-small cell lung cancer, hypertension, diarrhoea and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: alanine aminotransferase decreased, anorexia, aspartate aminotransferase decreased, blood potassium decreased, blood sodium decreased, interstitial lung disease, pneumonitis. Irinotecan dosage: DAILY DOSE:151MG-FREQ:INTERVAL: DAYS 1,8 EVERY 3 WEEKS. During the same period patient was treated with FRANDOL, URSO, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #5236295-4
Irinotecan side effect was reported by a Health Professional from JAPAN on Jan 31, 2007. Male patient, weighting 88.18 lb, was diagnosed with large intestine carcinoma and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, diarrhoea, hepatic function abnormal, large intestine perforation, malaise, pancytopenia. Irinotecan dosage: unknown. During the same period patient was treated with OMEPRAL, HYPEN, OXYCONTIN, FURTULON, MYSLEE, LASIX, NAUZELIN, LOXONIN. Patient died on 01/22/2007.
Irinotecan Side Effects Report #5018273-3
Irinotecan side effect was reported by a Physician from FRANCE on May 17, 2006. Female patient, 54 years of age, weighting 125.7 lb, was diagnosed with ill-defined disorder and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abdominal pain
, anorexia, aspartate aminotransferase increased, blood creatinine increased, blood culture positive, blood sodium decreased, dehydration, diarrhoea, dysphagia. Irinotecan dosage: unknown. During the same period patient was treated with AVASTIN, FLUOROURACIL, MORPHINE SULPHATE, OMEPRAZOLE, ZOLPIDEM TARTRATE, MACROGOL. Patient was hospitalized. Patient died on 03/06/2006.Irinotecan Side Effects Report #4941231-1
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 10, 2006. Female patient, 45 years of age, weighting 179.2 lb, was diagnosed with glioblastoma multiforme and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abdominal pain upper, abdominal wall disorder, anorexia, neutrophil count decreased, scan abdomen abnormal, tenderness. Irinotecan dosage: 447 MG. During the same period patient was treated with TEMOZOLOMIDE. Patient was hospitalized. Patient recovered.
Irinotecan Side Effects Report #4591486-0
Irinotecan side effect was reported by a Physician from on Feb 08, 2005. Male patient, 70 years of age, weighting 103.6 lb, was diagnosed with gastric cancer, decreased appetite and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, c-reactive protein increased, candida serology positive, disseminated intravascular coagulation, pulmonary fibrosis
, pyrexia, respiratory failure, respiratory moniliasis. Irinotecan dosage: 50 MG/M2 (CYCLIC), INTRAVENOUS. During the same period patient was treated with PACLITAXEL, DEXAMETHASONE PHOSPHATE, PREDNISONE. Patient was hospitalized. Patient died on 11/19/2004.Irinotecan Side Effects Report #4692264-4
Irinotecan side effect was reported by a Physician from on June 02, 2005. Female patient, 69 years of age, was diagnosed with gastric cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, dizziness
, fatigue, malaise, oedema, oedema peripheral. Irinotecan dosage: 106 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with TEGAFUR. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4699648-9
Irinotecan side effect was reported by a Physician from on June 10, 2005. Female patient, 69 years of age, was diagnosed with gastric cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, dizziness
, fatigue, malaise, oedema peripheral. Irinotecan dosage: 106 MG INTERMITTENT, INTRAVENOUS. During the same period patient was treated with TEGAFUR, MUCOSTA, GASMOTIN, ENZYMES, AMINOFLUID, GLYCERIN, HALCION. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4709503-3
Irinotecan side effect was reported by a Physician from JAPAN on June 23, 2005. Female patient, 69 years of age, was diagnosed with gastric cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, dizziness
, fatigue, malaise, oedema peripheral. Irinotecan dosage: unknown. During the same period patient was treated with IRINOTECAN HYDROCHLORIDE SOLUTION, TEGAFUR, INTRALIPID, MUCOSTA, GASMOTIN, ENZYMES, AMINOFLUID. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4556881-4
Irinotecan side effect was reported by a Physician from on Jan 07, 2005. Male patient, 37 years of age, weighting 174.2 lb, was diagnosed with gastric cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, cardiac failure, infection
, interstitial lung disease, lymphangiosis carcinomatosa, nausea , platelet count decreased, pulmonary oedema, white blood cell count decreased. Irinotecan dosage: 280 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with MITOMYCIN. Patient died on 03/08/2003.Irinotecan Side Effects Report #4643026-5
Irinotecan side effect was reported by a Physician from on Apr 08, 2005. Male patient, 37 years of age, weighting 174.2 lb, was diagnosed with gastric cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, blood beta-d-glucan increased, cardiac failure, cytomegalovirus antibody positive, interstitial lung disease, lymphangiosis carcinomatosa, nausea
, platelet count decreased, pleural effusion. Irinotecan dosage: 280 MG (INTERMITTENT), INTRAVENOUS. During the same period patient was treated with MITOMYCIN. Patient died on 03/08/2003.Irinotecan Side Effects Report #5200411-0
Irinotecan side effect was reported by a Consumer or non-health professional from JAPAN on Dec 26, 2006. Female patient was diagnosed with gastric cancer, nutritional support
, dyspepsia and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, aspartate aminotransferase increased, back pain , blood albumin decreased, diarrhoea, dizziness , eye discharge, fatigue, haemoglobin decreased. Irinotecan dosage: DAILY DOSE:80MG/M*2-FREQ:INTERMITTENT. During the same period patient was treated with TEGAFUR, INTRALIPID, MUCOSTA, GASMOTIN, ENZYMES. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #5664870-1
Irinotecan side effect was reported by a Health Professional from JAPAN on Mar 04, 2008. Female patient, weighting 116.8 lb, was diagnosed with gastric cancer, brain oedema, nutritional support
and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: altered state of consciousness, anorexia, diarrhoea, dysphagia, leukopenia, nausea , neutropenia, thrombocytopenia. Irinotecan dosage: DAILY DOSE:100MG. During the same period patient was treated with CISPLATIN, DECADRON, NASEA, PRIMPERAN, FULCALIQ. Patient was hospitalized. Patient died on 06/18/2007.Irinotecan Side Effects Report #4972054-5
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2006. Female patient, 21 years of age, was diagnosed with ependymoma and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abasia, anorexia, convulsion, device related infection, diarrhoea haemorrhagic, fall
, infusion related reaction, intracranial pressure increased, muscle spasms. Irinotecan dosage: 50 MG/M2 CYCLIC INTERVAL : 5 DAYS/WEEK, INTRAVENOUS. During the same period patient was treated with KEPPRA, BACTRIM, DIFLUCAN, ERLOTINIB, DECADRON. Patient was hospitalized and became disabled. Patient recovered.Irinotecan Side Effects Report #4645749-0
Irinotecan side effect was reported by a Physician from on Apr 11, 2005. Male patient, 70 years of age, weighting 141.3 lb, was diagnosed with colorectal cancer recurrent and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anorexia, condition aggravated, interstitial lung disease, nausea
, pelvic abscess. Irinotecan dosage: unknown. During the same period patient was treated with TEGAFUR URACIL, TEGAFUR GIMERACIL, TEGAFUR GIMERACIL. Patient died on 09/05/2004.Irinotecan Side Effects Report #4708418-4
Irinotecan side effect was reported by a Physician from UNITED STATES on June 21, 2005. Male patient, 95 years of age, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, blood creatine increased, blood culture positive, blood urea increased, condition aggravated, dehydration, diabetes mellitus, diarrhoea, dysphagia. Irinotecan dosage: 300 MG/M2 (300 MG/M2, CYCLIC), INTRAVENOUS. Patient was hospitalized. Patient died on 06/07/2005.
Irinotecan Side Effects Report #4747201-0
Irinotecan side effect was reported by a Physician from UNITED STATES on Aug 02, 2005. Male patient, 95 years of age, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, bacteria blood identified, blood urea increased, colorectal cancer metastatic, condition aggravated, dehydration, diabetes mellitus non-insulin-dependent, diarrhoea, dysphagia. Irinotecan dosage: 300 MG/M2 (300 MG/M2, CYCLIC), INTRAVENOUS. Patient was hospitalized. Patient died on 06/07/2005.
Irinotecan Side Effects Report #5156708-6
Irinotecan side effect was reported by a Physician from UNITED STATES on Nov 03, 2006. Male patient, 74 years of age, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, apnoea, diarrhoea, febrile neutropenia, gastrointestinal toxicity, haematocrit decreased, haemoglobin decreased, lymphocyte percentage decreased, monocyte count increased. Irinotecan dosage: 742 MG (CYCLICAL), INTRAVENOUS. During the same period patient was treated with CETUXIMAB, ASPIRIN, IBUPROFEN, METFORMIN, OLMESARTAN MEDOXOMIL, TEMAZEPAM, SULFISOXAZOLE. Patient was hospitalized. Patient died on 11/28/2004.
Irinotecan Side Effects Report #4701080-6
Irinotecan side effect was reported by a Physician from on June 17, 2005. Male patient, 74 years of age, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, apnoea, blood albumin decreased, blood potassium decreased, febrile neutropenia, frequent bowel movements, gastrointestinal toxicity, haematocrit decreased, incontinence. Irinotecan dosage: 742 MG (CYCLIC) INTRAVENOUS. During the same period patient was treated with CETUXIMAB, ACETYLSALICYLIC ACID SRT, IBUPROFEN, METFORMIN, OLMESARTAN MEDOXOMIL, TEMAZEPAM, SULFISOXAL. Patient was hospitalized. Patient died on 11/28/2004.
Irinotecan Side Effects Report #5154527-8
Irinotecan side effect was reported by a Consumer or non-health professional from GERMANY on Feb 10, 1998. Male patient, 59 years of age, was diagnosed with colorectal cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, back pain
, cardiac disorder, constipation , fatigue, hyperhidrosis, hypertension, peripheral coldness. Irinotecan dosage: 350 MG/M*2 (EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with PROSTAGUTT. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #6056845-8
Irinotecan side effect was reported by a Health Professional from JAPAN on Jan 19, 2009. Female patient was diagnosed with colorectal cancer
and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, disease progression, gastric dilatation, nausea . Irinotecan dosage: 270 MG, 1X/DAY, EVERY 2 WEEKS. During the same period patient was treated with FLUOROURACIL, SUNITINIB MALATE, BROTIZOLAM, FAMOTIDINE, MAGNESIUM OXIDE, SENNOSIDE A. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #6087412-8
Irinotecan side effect was reported by a Health Professional from JAPAN on Feb 12, 2009. Female patient was diagnosed with colorectal cancer
and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, gastric dilatation, vomiting. Irinotecan dosage: 270 MG, 1X/DAY, EVERY 2 WEEKS. During the same period patient was treated with FLUOROURACIL, SUNITINIB MALATE, BROTIZOLAM, FAMOTIDINE, MAGNESIUM OXIDE, SENNOSIDE A. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #6135351-6
Irinotecan side effect was reported by a Physician from FRANCE on Mar 17, 2009. Female patient was diagnosed with colorectal cancer
and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, asthenia. Irinotecan dosage: unknown. During the same period patient was treated with MORPHINE SULPHATE, FLUOROURACIL, CETUXIMAB. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4569509-4
Irinotecan side effect was reported by a Physician from on Jan 19, 2005. Male patient, 66 years of age, weighting 130.1 lb, was diagnosed with colon cancer metastatic and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, aspiration, bronchopneumonia, dehydration, diarrhoea, disease progression, dysarthria, haemoglobin decreased. Irinotecan dosage: 240 MG (CYCLIC), INTRAVENOUS. During the same period patient was treated with EPINEPHRINE HYDROCHLORIDE, ACETYLSALICYLIC ACID SRT, ENALAPRIL MALEATE, NORVASC, ISOSORBIDE DINITRATE, TICLOPIDINE, MORPHINE SULPHATE, PROCHLORPERAZINE. Patient died on 07/19/2004.
Irinotecan Side Effects Report #5006886-4
Irinotecan side effect was reported by a Physician from JAPAN on Apr 28, 2006. Male patient, 77 years of age, was diagnosed with colon cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abnormal faeces, anorexia, ascites, blood pressure immeasurable, cancer pain, cardiac arrest
, diarrhoea, incoherent, interstitial lung disease. Irinotecan dosage: 100 MG (100 MG, DAILY), INTRAVENOUS. During the same period patient was treated with TEGAFUR, MUCOSTA, MAGNESIUM OXIDE, MORPHINE, FENTANYL, MOBIC, PRIMPERAN, DOGMATYL. Patient died on 04/07/2006.Irinotecan Side Effects Report #5034327-X
Irinotecan side effect was reported by a Physician from JAPAN on June 07, 2006. Male patient, 77 years of age, was diagnosed with colon cancer and was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abnormal behaviour, abnormal faeces, acute respiratory distress syndrome, anorexia, blood pressure immeasurable, cancer pain, cardiac arrest
, condition aggravated, diarrhoea. Irinotecan dosage: 100 MG (100 MG, DAILY), INTRAVENOUS. During the same period patient was treated with TEGAFUR, MUCOSTA, MAGNESIUM OXIDE, MORPHINE, FENTANYL, MOBIC, PRIMPERAN, DOGMATYL. Patient died on 04/07/2006.Irinotecan Side Effects Report #4546725-9
Irinotecan side effect was reported by a Physician from on Nov 15, 2004. Female patient, 57 years of age, weighting 163.1 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, anxiety
, blood lactate dehydrogenase increased, blood potassium increased, blood sodium decreased, confusional state, dehydration, disorientation, fluid intake reduced. Irinotecan dosage: 130 MG (CYCLIC), INTRAVENOUS. During the same period patient was treated with PLATAMINE, KETOPROFEN, ENALAPRIL, NITRENDIPINE, THEOPHYLLINE, DIAZEPAM, BETAHISTINE. Patient was hospitalized. Patient died on 10/01/2002.Irinotecan Side Effects Report #5130665-0
Irinotecan side effect was reported by a Health Professional from UNITED STATES on Oct 18, 2006. Female patient, weighting 177.3 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: abdominal pain upper, anorexia, constipation
, cytomegalovirus infection , nausea . Irinotecan dosage: unknown. During the same period patient was treated with CELEBREX, OXYCONTIN, COMPAZINE, KYTRIL, SENNA, COLACE, REGLAN. Patient was hospitalized. Patient recovered.Irinotecan Side Effects Report #4692067-0
Irinotecan side effect was reported by a Consumer or non-health professional from on June 16, 2005. Male patient, weighting 168.4 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, bone pain, constipation
, dehydration, diarrhoea, flat affect, international normalised ratio increased, malaise, nausea . Irinotecan dosage: 60 MG/M2 IV OVER 90 MIN ON DAYS 1, 8 + 15 Q 4 WKS.. During the same period patient was treated with CISPLATIN. Patient recovered.Irinotecan Side Effects Report #4847091-1
Irinotecan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 05, 2005. Male patient, weighting 240.3 lb, was treated with Irinotecan. After drug was administered, patient experienced the following side effects: anorexia, dysgeusia, dyspnoea exertional, fatigue, weight decreased. Irinotecan dosage: unknown. During the same period patient was treated with CISPLATIN, ETOPOSIDE. Patient died.